osimertinib
astrazeneca
['adaura', 'nsclc', 'lcsm,(-blcsm)', 'sclc', 'osimertinib', 'aura ,(-laura)']
#asco23 publication in for plenary lba3 by et al: os analysis from the adaura trial of adjuvant osimertinib in patients with resected egfrm stage ib iiia nsclc. view abstract #lcsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.